Why VigiLanz

The work we do matters, and we work hard to make it happen. Dynamic. Inquisitive. Smart. Committed. At VigiLanz, you’ll notice that our people are curious and our projects move fast. Our solutions are changing lives for the better, and we look forward to innovating and leading for years to come.

Leadership

Dr. Goldsteen is the co-founder of VigiLanz, and serves as Chairman and CEO. He is a founder and former Chairman and CEO of Vascular Science, Inc., purchased by St. Jude Medical (NASDAQ:STJ). He is the founder and Managing Partner of Global Capital Investments, LLC, a boutique merchant banking group. He previously served as a board member/financier of SurVivaLink, a medical device manufacturer sold to Cardiac Science (NASDAQ:DFIB), MediaDVX, a digital media provider sold to NetStar LP, InfoPet, a veterinary microchipping company, and Quantech, Ltd, a medical diagnostics company. From 1988–1993 he served as Vice President of Medical Affairs for Emergency Services at Health One, a predecessor of Allina Hospitals and Clinics, a diversified healthcare delivery organization. Dr. Goldsteen is a graduate of the University of Minnesota Medical School, performing his residency in Internal Medicine at Hennepin County Medical Center in Minneapolis, MN. He received board certifications in internal medicine and emergency medicine. He received his M.B.A. in 1994 from the Carlson School of Management at the University of Minnesota.

Adam has been with VigiLanz since 2001 and is one of its founding members. He has expertise in designing, building and supporting large-scale data driven applications and is responsible for driving the technological vision of the company. Prior to joining VigiLanz, Adam held technical positions with DaVinci Software, Software Architects, and Red Sky Technologies. He holds a B.A. in political science from the University of Kansas, as well as an M.A. in Public Administration from the University of Illinois at Chicago.

Pat serves as Chief Financial Officer. Pat has significant senior executive leadership experience in operations, financial management and strategic business initiatives. He has helped lead high-performance, emerging growth firms, as well as Fortune 500 companies, and has also served in the private equity sector, successfully improving operational results with a broad array of portfolio companies. He holds a B.S. in accounting and an M.B.A. in business taxation from the University of Minnesota. Pat also holds an M.B.A. from the University of Chicago.

Stacy joined VigiLanz in 2011 to advance the development of VigiLanz Infection Prevention. In 2014 she became VP of Clinical Intelligence, overseeing the ongoing development and clinical support of the VigiLanz solutions for Infection Prevention, Antimicrobial Stewardship, and Pharmacy. Tasked with further product expansion she successfully rolled out Clinical and Quality services, AU/AR MU3 certification and direct import for NHSN. An RN, Stacy has presented nationally and published research in the areas of outbreaks, antibiotic resistance, bio-preparedness and infection control.

Steve leads the new business, sales operations and customer relationship management organizations worldwide. He has a strong track record for achieving significant growth and delivering effective healthcare information technology solutions to customers that improve patient care and operational performance. Prior to joining VigiLanz, he led the sales and operations activities for a medical imaging firm, driving growth from early-stage to nearly $100 million in annual revenues. Steve holds a degree in biological sciences from the University of Minnesota, with a concentration in chemistry and business.

Erik is an accomplished Global Marketing Software Executive with a broad background including marketing, sales operations, business development, and digital transformation in Health Information Technology, Medical Technology and Supply Chain industries. Erik has worked with notable brands such as 3M, Wolters Kluwer and HighJump Software in helping to deliver top and bottom line growth for multiple products and markets in many states and global geographies. Erik received his undergraduate degree in Marketing from Iowa State University and is a certified Six Sigma Black Belt.

Craig leads the company’s technical organization. He oversees all software development projects devoted to continuous enhancement of VigiLanz’s current product portfolio, as well as managing the company’s new product pipeline, system security and interoperability services with third-party EMR platforms and best-of-breed vendors. Craig has extensive experience in systems design and relational data model design. His background includes architecting and leading software development in the manufacturing, financial services, telecom and retail services sectors. Craig holds a B.S. in computer science from Northern Illinois University.

Liz plans, directs and coordinates operations to support VigiLanz’s client effectiveness and user experience with the company’s real-time intelligence solutions and services. She oversees all client implementation projects, user readiness and ongoing client custom requirements requests. She has extensive experience helping build operational capacity and discipline at several early-stage organizations and has held operations management and leadership roles at FORTUNE 500 firms doing business in the airline and telecommunications sectors. Liz obtained an undergraduate degree in computer science and an M.B.A. in operations management, both from DePaul University.

Board of
Directors

+
x

David Goldsteen

Chairman

Dr. Goldsteen is the co-founder of VigiLanz, and serves as Chairman and CEO. He is a founder and former Chairman and CEO of Vascular Science, Inc., purchased by St. Jude Medical (NASDAQ:STJ). He is the founder and Managing Partner of Global Capital Investments, LLC, a boutique merchant banking group. He previously served as a board member/financier of SurVivaLink, a medical device manufacturer sold to Cardiac Science (NASDAQ:DFIB), MediaDVX, a digital media provider sold to NetStar LP, InfoPet, a veterinary microchipping company, and Quantech, Ltd, a medical diagnostics company. From 1988–1993 he served as Vice President of Medical Affairs for Emergency Services at Health One, a predecessor of Allina Hospitals and Clinics, a diversified healthcare delivery organization. Dr. Goldsteen is a graduate of the University of Minnesota Medical School, performing his residency in Internal Medicine at Hennepin County Medical Center in Minneapolis, MN. He received board certifications in internal medicine and emergency medicine. He received his M.B.A. in 1994 from the Carlson School of Management at the University of Minnesota.

+
x

Randy Tofteland

Director

Randy Tofteland is an experienced corporate executive having served as CEO and senior executive for several global software companies. As CEO, Randy led the sale of SoftBrands to Infor and Golden Gate Capital. Randy also served as Epicor’s EVP of its Retail Division and assisted in the sale of Epicor to APAX Partners. Randy currently serves on the board of CINgroup and is the Vice Chairman of VigiLanz.

+
x

David Ableson, Director

Director

David Abelson, MD has had a career in medicine, health system design, and executive leadership. David trained in general internal medicine and after a time in private practice joined a large integrated delivery system, Park Nicollet Health Services. In 2010 David became CEO of Park Nicollet Health Services and led the direction of Park Nicollet to value-based payment resulting in a merger with HealthPartners in 2013. As Senior Vice President of HealthPartners and CEO of Park Nicollet, David led a delivery system with multiple hospitals, clinics and specialties with a combined annual revenue of $2.2 billion. David retired in 2014 and is now President of the Institute for Clinical Systems Improvement.

+
x

David Klass

Founder and Observer

Dr. Klass is the developer of VigiLanz’s prototype technology and served as Chief Medical Officer from the company’s founding in 2001 through his retirement in 2014. He has had a long-term interest in the logic of pharmacy ordering systems and the relation of these systems to laboratory results and the creation of tools that could mine and combine both systems intelligently. Dr. Klass graduated from the University of Manitoba and the University of Chicago. He lives in Spain and Chicago.

+
x

Jeff Zalasky

Founder and Observer

Jeff Zalasky, JD served as General Counsel for VigiLanz until his retirement in 2014 and currently serves as an observer of the board of directors. He is a vice president of Global Capital Investments, LLC, a boutique merchant banking group. Jeff served on the board of Vascular Science, Inc. prior to its acquisition by St. Jude Medical in 1999, and he was a board observer for MediaDVX. Jeff received his law degree from Hamline University School of Law in St. Paul, Minnesota.

Our Partners

As a part of the VigiLanz Partner Ecosystem, we’ll collaborate to build healthier hospitals. To inquire about a partnership, please complete our contact form.

PARTNER WITH US

Careers

If you’d like to learn more about our culture and possible openings in the future, let us know. We’re always on the lookout for new talent and would love to be in touch.

Current Openings:

Contact Us

Ready to see your data in action?

Request a demo